Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0457 Transporter Info
Gene Name	SLC6A5
Transporter Name	Sodium- and chloride-dependent glycine transporter 2
Gene ID	9152
UniProt ID	Q9Y345

Post-Translational Modification of This DT
Overview of SLC6A5 Modification Sites with Functional and Structural Information
Sequence	M D C S A P K E M N K L P A N S P E A A A A Q G H P D G P C A P R T S P E Q E L P A A A A P P P P R V P R S A S T G A Q T F Q S A D A R A C E A E R P G V G S C K L S S P R A Q A A S A A L R D L R E A Q G A Q A S P P P G S S G P G N A L H C K I P F L R G P E G D A N V S V G K G T L E R N N T P V V G W V N M S Q S T V V L A T D G I T S V L P G S V A T V A T Q E D E Q G D E N K A R G N W S S K L D F I L S M V G Y A V G L G N V W R F P Y L A F Q N G G G A F L I P Y L M M L A L A G L P I F F L E V S L G Q F A S Q G P V S V W K A I P A L Q G C G I A M L I I S V L I A I Y Y N V I I C Y T L F Y L F A S F V S V L P W G S C N N P W N T P E C K D K T K L L L D S C V I S D H P K I Q I K N S T F C M T A Y P N V T M V N F T S Q A N K T F V S G S E E Y F K Y F V L K I S A G I E Y P G E I R W P L A L C L F L A W V I V Y A S L A K G I K T S G K V V Y F T A T F P Y V V L V I L L I R G V T L P G A G A G I W Y F I T P K W E K L T D A T V W K D A A T Q I F F S L S A A W G G L I T L S S Y N K F H N N C Y R D T L I V T C T N S A T S I F A G F V I F S V I G F M A N E R K V N I E N V A D Q G P G I A F V V Y P E A L T R L P L S P F W A I I F F L M L L T L G L D T M F A T I E T I V T S I S D E F P K Y L R T H K P V F T L G C C I C F F I M G F P M I T Q G G I Y M F Q L V D T Y A A S Y A L V I I A I F E L V G I S Y V Y G L Q R F C E D I E M M I G F Q P N I F W K V C W A F V T P T I L T F I L C F S F Y Q W E P M T Y G S Y R Y P N W S M V L G W L M L A C S V I W I P I M F V I K M H L A P G R F I E R L K L V C S P Q P D W G P F L A Q H R G E R Y K N M I D P L G T S S L G L K L P V K D L E L G T Q C
PTM type	X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A5			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	343
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A5 Asparagine 343 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A5			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	353
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A5 Asparagine 353 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A5			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	358
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A5 Asparagine 358 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC6A5			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	364
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A5 Asparagine 364 has the potential to affect its expression or activity.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A5			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	498
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC6A5 Cystine 498 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A5			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	752
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC6A5 Cystine 752 has the potential to affect its expression or activity.
Phosphorylation
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	May contribute to the turnover of the glycine SLC6A5 GlyT2			[3]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	157
Experimental Material(s)	Neuro-2a (N2a) Cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A5 Serine 157 have been reported to possibly contribute to its turnover.
PTM Phenomenon 2	Have the potential to influence SLC6A5			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	83
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A5 Serine 83 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A5			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A5 Serine 84 has the potential to affect its expression or activity.
Ubiquitination
Lysine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Accelerating SLC6A5 degradation rate			[6] , [7]
Role of PTM	Degradation via Proteosome
Affected Drug/Substrate	Glycine	Results for Drug	Affecting the inward transport of glycine
Modified Residue	Lysine	Modified Location	751
Related Enzyme	E3 ubiquitin-protein ligase LNX (LNX1) Ligand of Numb protein X 2 (LNX2)
Experimental Material(s)	Male Wistar rats; African green monkey kidney fibroblast-like (COS-7) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A5 Lysine 751 have been reported to accelerate its degradation, thereby affecting its expression or activity.
PTM Phenomenon 2	Accelerating SLC6A5 degradation rate			[6] , [7]
Role of PTM	Degradation via Proteosome
Affected Drug/Substrate	Glycine	Results for Drug	Affecting the inward transport of glycine
Modified Residue	Lysine	Modified Location	773
Related Enzyme	E3 ubiquitin-protein ligase LNX (LNX1) Ligand of Numb protein X 2 (LNX2)
Experimental Material(s)	Male Wistar rats; African green monkey kidney fibroblast-like (COS-7) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A5 Lysine 773 have been reported to accelerate its degradation, thereby affecting its expression or activity.
PTM Phenomenon 3	Accelerating SLC6A5 degradation rate			[6] , [7]
Role of PTM	Degradation via Proteosome
Affected Drug/Substrate	Glycine	Results for Drug	Affecting the inward transport of glycine
Modified Residue	Lysine	Modified Location	787
Related Enzyme	E3 ubiquitin-protein ligase LNX (LNX1) Ligand of Numb protein X 2 (LNX2)
Experimental Material(s)	Male Wistar rats; African green monkey kidney fibroblast-like (COS-7) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A5 Lysine 787 have been reported to accelerate its degradation, thereby affecting its expression or activity.
PTM Phenomenon 4	Accelerating SLC6A5 degradation rate			[6] , [7]
Role of PTM	Degradation via Proteosome
Affected Drug/Substrate	Glycine	Results for Drug	Affecting the inward transport of glycine
Modified Residue	Lysine	Modified Location	791
Related Enzyme	E3 ubiquitin-protein ligase LNX (LNX1) Ligand of Numb protein X 2 (LNX2)
Experimental Material(s)	Male Wistar rats; African green monkey kidney fibroblast-like (COS-7) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A5 Lysine 791 have been reported to accelerate its degradation, thereby affecting its expression or activity.

References
1	The role of N-glycosylation in transport to the plasma membrane and sorting of the neuronal glycine transporter GLYT2. J Biol Chem. 2001 Jan 19;276(3):2168-73.
2	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3	Phosphorylation of Serine 157 Protects the Rat Glycine Transporter GlyT2 from Calpain Cleavage. J Mol Neurosci. 2020 Aug;70(8):1216-1224.
4	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5	Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48.
6	E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2. Sci Rep. 2019 Oct 18;9(1):14944.
7	Constitutive endocytosis and turnover of the neuronal glycine transporter GlyT2 is dependent on ubiquitination of a C-terminal lysine cluster. PLoS One. 2013;8(3):e58863.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence